Phaeochromocytoma
Appearance
Epidemiology
[edit | edit source]- Affects about 0.2% of patients with HTN
- Peak incidence between 40-50yo
- Familial cases can manifest earlier and more often multifocal
- '10%' axiom is not really true in modern times
- Bilateral
- Malignant
- Extra-adrenal
- Familial
Risk factors
[edit | edit source]- MEN 2 (50% penetrant)
- VHL (10-20% penetrant)
- NFT 1 (1-5% penetrant)
- Germline mutations in succinate dehydrogenase (lifetime penetrance >75%)
- See separate topic under 'oncology'
Pathophysiology
[edit | edit source]- Malignancy
- 2.5-40% are malignant, depending on underlying phenotype
- No histopathologic criteria exist for determining malignancy
- Malignancy is defined by development of metastases (defined as distant implants in locations where neuroectodermal tissues are not normally found)
- Most common metastatic sites are axial skeleton, lymph nodes, liver, lung and kidney
- Paragangliomas
- Tend to secrete noradrenaline rather than adrenaline
Presentation
[edit | edit source]- Classic triad - headache, diaphoresis, palpitations
- Almost all patients will have at least one
- HTN (90%) - can be episodic or sustained
Diagnosis
[edit | edit source]- Biochemical
- Need to confirm elevated levels of catecholamines and their metabolites in body fluids. The exact profiles vary; tumours have different characteristics depending on their expression of synthetic and degradative enzymes.
- Testing rationale
- Plasma metanephrines/normetanephrines: sensitivity 99%, specificity 85%
- Drawn in supine position, and after an overnight fast, avoiding caffeine and nicotine
- 24-hour urine catecholamines and metabolites: specificity 99%
- Considered positive when total metanephrines or any single catecholamine fraction is elevated above its cut-off value. This maintains high specificity and yields a sensitivity of about 88%.
- Given that phaeochromocytoma is a rare diagnosis within a large pool of hypertensive patients, false-positives are a real problem, and specificity is crucial. It has been estimated that false-positives outnumber true positives by up to 30:1 when plasma metanephrines are used as screening.
- Plasma metanephrines/normetanephrines: sensitivity 99%, specificity 85%
- Drugs and conditions that can cause elevated metanephrines:
- Sympathomimetics
- Phenoxybenzamine
- Paracetamol
- Psychotropic drugs including TCAs
- Major physical or psychological stressors
- Approach
- Start with serum metanephrines
- If positive, test urine
- Clonidine suppression testing (give 0.3mg oral clonidine) can be used but is uncommonly needed
- Anatomical localisation/staging
- CT or MRI can be used - CT is often more useful, but MRI is slightly more sensitive
- CT - characteristic - heterogenous with higher attenuation. All phaeos have HU > 10.
- MRI - bright on T2
- Scintigraphy with (131)I or (123)I-labeled metaiodobenzylguanidine (MIBG) can be performed when multifocal or malignant disease is suspected
- Highly specific, but sensitivity only 77-90%
- PET (F-DOPA) which somehow uses DOTATATE is developing as superior to MIBG, but apparently isn't widely available yet
- CT or MRI can be used - CT is often more useful, but MRI is slightly more sensitive
- Check for genetic syndromes
- Histopathological
- PASS score - composite of capsular or vascular invasion, mitotic rate, necrosis
- GAPP - phaeos and paragangliomas - combines histopathological and clinical criteria - probably the more favoured score now
Differential diagnosis
[edit | edit source]- Hyperthyroidism
- Hypoglycaemia
- CAD
- CCF
- CVA
- Drug effects
- Panic disorder
Phaeochromocytoma in pregnancy
[edit | edit source]- Rare, but potentially fatal (29% mortality if diagnosed in labour or post-partum)
- Adrenalectomy in second trimester
- Postpone surgery until after delivery if diagnosed in third trimester
Treatment approach
[edit | edit source]- Surgical resection of primary and metastatic lesions, which can also have palliative responses in the absence of a cure, due to reducing the systemic impact of catecholamine release
- Malignant tumours are minimally responsive to radiotherapy and chemotherapy
- I-MIBG radionuclide therapy has a 22% complete or partial response rate, with significant toxicities and questionable long-term benefit
- Chronic medical management can be achieved with alpha1-adrenergic blockers
Surgery
[edit | edit source]- Minimise tumour manipulation, avoid rupture
- Tumours tend to be highly vascular and adherent to adjacent structures
- Mostly can be removed laparoscopically, but prefer open with signs of local invasion or tumours >6cm
Peri-op care
[edit | edit source]- Pre-op care
- Start with phenoxybenzamine 10mg BD (alpha-adrenergic blockade) as soon as the biochemical diagnosis is made
- This drug is a non-specific, non-competitive (irreversible), long-acting (half-life 24 hours), alpha-adrenergic antagonist
- Side effects postural hypotension and nasal congestion (which can actually serve as a useful indicator of adequate blockade)
- Other options would be prazosin or doxazosin
- Titrate upwards every 2-3 days to a maximum of 40mg TDS to achieve normalisation of HR and BP
- Calcium channel blockers can be added if this is inadequate BP control after titration
- Beta blockers can be added with persistent tachycardia
- Pre-op conditioning should last at least two weeks to allow adequate reversal of alpha-adrenergic receptor down-regulation. This restores sensitivity to vasopressor agents, which can then be used to treat the patient post-operatively.
- Pre-operative volume repletion is generally not indicated - once blockade is achieved, patients can restore volume by drinking to thirst
- Needs pre-op staging
- Start with phenoxybenzamine 10mg BD (alpha-adrenergic blockade) as soon as the biochemical diagnosis is made
- Intra-op HTN
- Caused by stimulation of catecholamine release by induction agents, along with direct manipulation of the tumour
- Intra-operative alpha-adrenergic blockade followed by aggressive volume repletion and alpha-adrenergic agonists in the immediate post-op period
- Art-line is required
- Pause for 10 mins if BP getting very high
- Ligate vein before arteries
- Post-op HTN
- Can be profound - state of hypovolaemia created by the presence of excess circulating catecholamines. Sudden withdrawal leads to peripheral arteriolar vasodilation and a dramatic increase in venous capacitance, which together may precipitate CV collapse.
- Aggressively resuscitate if hypotension or oliguria occurs
- Vasopressors may be required
Prognosis
[edit | edit source]- Surgery is curative in >90% of cases
Indications for genetic testing
[edit | edit source]- Age <45yo
- Multiple tumours
- Head and neck paraganglioma